Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.
Using a panel of neutralizing monoclonal antibodies, we have mapped epitopes in domain III of the envelope protein of the New York strain of West Nile virus. The ability of monoclonal antibodies that recognize these epitopes to neutralize virus appeared to differ between lineage I and II West Nile virus strains, and epitopes were located on the upper surface of domain III at residues E307, E330, and E332.
Beasley
David W C
DW
WHO Collaborating Center for Tropical Diseases, Sealy Center for Vaccine Development, Department of Pathology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0609, USA.
Barrett
Alan D T
AD
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002462:Cell Membrane / Q000378:metabolism; D018604:Epitope Mapping; D051379:Mice; D009500:Neutralization Tests; D011994:Recombinant Proteins / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology* / Q000502:physiology; D014774:Virulence; D014902:West Nile virus / Q000276:immunology* / Q000472:pathogenicity
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D014759:Viral Envelope Proteins